Sangel Capital Investor

one of the earliest globally operating professional biomedical venture capital institutions in China
Headquarters: Shenzhen, Guangdong, China
Funding Status: Private
Investor Type: Venture Capital
Investment Stage: Early Stage Venture, Seed
Number Of Exits: 1
Investors Number: 25

Visit Website
liuyanzhan@sangelvc.com
Register and Claim Ownership